Cantor starts MiMedx at overweight, cites valuation, product offerings (NASDAQ:MDXG)
2024-07-02
Artystarty Cantor Fitzgerald initiated coverage of MiMedx Group (NASDAQ:MDXG) with an overweight rating, citing valuation and the wound care product maker’s offerings. The investment bank said it has a favorable view of the estimated $3.9B advanced wound care and surgical markets. It added that it sees MiMedx’s product portfolio asContinue Reading